Spevigo

Active Ingredient(s): Spesolimab-sbzo
FDA Approved: * September 1, 2022
Pharm Company: * BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Category: Immunosuppressive
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Spevigo 60 mg/ml Intravenous Injection
NDC: 0597-0035
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.